RankingsPricing
  1. JP-listed companies
  2. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
  3. Financials
  4. Total non-current liabilities

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.JP:2395

Market cap
¥78.5B
P/E ratio
22.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal non-current liabilities (Million JPY)YoY (%)
Mar 31, 202523,075+24.23%
Mar 31, 202418,574+88.16%
Mar 31, 20239,871+58.82%
Mar 31, 20226,216-32.57%
Mar 31, 20219,218-4.67%
Mar 31, 20209,669+19.62%
Mar 31, 20198,084-29.03%
Mar 31, 201811,390-19.24%
Mar 31, 201714,104+14.95%
Mar 31, 201612,270+5.93%
Mar 31, 201511,583

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)